PMV Pharmaceuticals Inc (NASDAQ: PMVP) is -49.35% lower on its value in year-to-date trading and has touched a low of $1.17 and a high of $7.64 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PMVP stock was last observed hovering at around $1.60 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $1.57, the stock is 2.68% and -0.25% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.13 million and changing -1.87% at the moment leaves the stock -16.22% off its SMA200. PMVP registered -78.98% loss for a year compared to 6-month loss of -16.27%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -1.26% gain in the last 1 month and extending the period to 3 months gives it a -13.74%, and is 1.29% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.90% over the week and 5.20% over the month.
PMV Pharmaceuticals Inc (PMVP) has around 63 employees, a market worth around $80.89M and $0.00M in sales. Distance from 52-week low is 33.62% and -79.45% from its 52-week high. The company has generated returns on investments over the last 12 months (-21.61%).
The EPS is expected to grow by 24.01% this year.
PMV Pharmaceuticals Inc (PMVP) Top Institutional Holders
122.0 institutions hold shares in PMV Pharmaceuticals Inc (PMVP), with institutional investors hold 89.96% of the company’s shares. The shares outstanding are 51.45M, and float is at 43.78M with Short Float at 2.48%. Institutions hold 87.62% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 6.48 million shares valued at $10.49 million. The investor’s holdings represent 12.5866% of the PMVP Shares outstanding. As of 2024-06-30, the second largest holder is ARROWMARK COLORADO HOLDINGS LLC with 2.8 million shares valued at $$4.54 million to account for 5.4519 of the shares outstanding. The other top investors are SIO CAPITAL MANAGEMENT, LLC which holds 2.71 million shares representing 5.2646% and valued at over $4.39 million, while EUCLIDEAN CAPITAL LLC holds 5.1076 of the shares totaling 2.63 million with a market value of $4.26 million.
PMV Pharmaceuticals Inc (PMVP) Insider Activity
The most recent transaction is an insider sale by ORBIMED ADVISORS LLC,the company’s10% Owner. SEC filings show that ORBIMED ADVISORS LLC sold 87,786 shares of the company’s common stock on Nov 22 ’23 at a price of $2.23 per share for a total of $0.2 million. Following the sale, the insider now owns 0.0 shares.
PMV Pharmaceuticals Inc disclosed in a document filed with the SEC on Sep 15 ’23 that Jalota Deepika (Chief Development Officer) sold a total of 4,104 shares of the company’s common stock. The trade occurred on Sep 15 ’23 and was made at $6.62 per share for $27168.0. Following the transaction, the insider now directly holds 29946.0 shares of the PMVP stock.
Still, SEC filings show that on Sep 15 ’23, Alland Leila (Chief Medical Officer) disposed off 6,291 shares at an average price of $6.62 for $41646.0. The insider now directly holds 45,909 shares of PMV Pharmaceuticals Inc (PMVP).
